Skip to content

ASSEMED

Active
Private limited companyfounded 1994active for 32 yearsRue des Bergeries(Wal) 12, 5650 Walcourt, BelgiumKBO/BCE: BE 0452.605.265
Summary

ASSEMED has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €964,849 and a net result of €27,907. Equity has been growing by about 4.7% per year since 2018. Its solvency ranks better than 95% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-04-1994 Normal situation
Activity
General medical practice NACE 86210
Joint committee
330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2023
Establishment unit
2.227.980.627 5650 Walcourt, since 23-04-1994
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€61,723
▼ 55.9%
Turnover
≈ €140,000
estimated
Profit
€27,907
▼ 55.1%
Equity
€964,849
▲ 3.0%
Total assets
€986,708
▲ 2.3%
  • 2025 accounts filed 20 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 33.95, cash €192,343Size: total assets €986,708Equity €964,849 (97.8% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 49% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 97.8% of total assets
Liquidity 74-13
short-term debt 2.0% · cash 19.5%
Profitability 72-5
return on assets 2.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €90,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 33.95 (26.55 in 2024), above the usual 1.5. Short-term debt is 2% and cash 19.5% of total assets. 2.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 56% on liquidity, 16% on profitability and 43% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 33.95, cash €192,343
NBB · annual accounts
lowers risk · Size: total assets €986,708
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €964,849 (97.8% of total assets)
NBB · annual accounts
neutral · A punctual record breaks
This company filed 6 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
20 days late
2024
31 days early
2023
43 days early
2022
55 days early
2021
38 days early
2020
45 days early
2019
64 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 37 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 63.0% · 20,700 companies 97.8% View
  • Positive: 8 profitable years in a rowprofit 2025: €27,907 8 years View

Recent changes

  1. · Gazette deed Appointment: VAN ASSCHE Philippe Albert Jean Jacques (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as ASSEMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1m and €1.4m, founded between 1991 and 2004.

CompanyTotal assetsGross margin
ASSEMED Walcourt€1.0m€0.06m
MEDICOURT Ciney€1.0m€0.07m
DOKTER VAN ENGELEN PATRICK Antwerpen€1.2m€0.06m
DR. DOMINICUS JAN Pelt€1.0m€0.07m
DOKTER DE KEYZER, algemene geneeskunde Boom€1.3m€0.07m
DR. STEVE VANDEKERKHOVE Ninove€1.1m€0.06m
WELLEMAN, huisartsengeneeskunde Temse€1.4m€0.07m
Full comparison

Key facts about ASSEMED

What is the company number of ASSEMED?
The company number of ASSEMED is 0452.605.265. The VAT number is the same number with BE in front: BE 0452.605.265.
Where is ASSEMED based?
The registered office is at Rue des Bergeries(Wal) 12, 5650 Walcourt.Company details
What does ASSEMED do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of ASSEMED?
The legal form of ASSEMED is Private limited company (BV).
When was ASSEMED founded?
ASSEMED was founded on 23-04-1994.
Is ASSEMED still active?
Yes, ASSEMED is an active enterprise in the KBO register.
How many employees does ASSEMED have?
ASSEMED had an average of 0.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does ASSEMED fall under?
In its 2023 annual accounts, ASSEMED states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of ASSEMED?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €61,723 and 32 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.
Is ASSEMED profitable?
In financial year 2025, ASSEMED made a profit of €27,907.
Where can I find the annual accounts of ASSEMED?
ASSEMED filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ASSEMED due?
ASSEMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.